Page last updated: 2024-09-05

ramelteon and Parkinson Disease

ramelteon has been researched along with Parkinson Disease in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	2 (50.00)	2.80

Authors

Authors	Studies
Gu, C; Liu, CF; Liu, JY; Sun, HY; Wang, F; Wang, GH; Wei, SZ; Zhang, YT	1
Li, C; Liu, R; Mai, Y; Zhang, Y	1
Kawase, S; Nakashima, K; Nomura, T; Watanabe, Y	1
Kashihara, K; Maeda, T; Mishima, T; Nakashima, K; Nomura, T; Takigawa, H; Tsuboi, Y	1

Trials

1 trial(s) available for ramelteon and Parkinson Disease

Article	Year
Beneficial Effects of Ramelteon on Rapid Eye Movement Sleep Behavior Disorder Associated with Parkinson's Disease - Results of a Multicenter Open Trial. Internal medicine (Tokyo, Japan), 2016, Volume: 55, Issue:3 Topics: Aged; Antiparkinson Agents; Female; Humans; Hypnotics and Sedatives; Indenes; Japan; Levodopa; Male; Middle Aged; Parkinson Disease; REM Sleep Behavior Disorder; Surveys and Questionnaires; Treatment Outcome	2016

Article

Year

Beneficial Effects of Ramelteon on Rapid Eye Movement Sleep Behavior Disorder Associated with Parkinson's Disease - Results of a Multicenter Open Trial.

Internal medicine (Tokyo, Japan), 2016, Volume: 55, Issue:3

Topics: Aged; Antiparkinson Agents; Female; Humans; Hypnotics and Sedatives; Indenes; Japan; Levodopa; Male; Middle Aged; Parkinson Disease; REM Sleep Behavior Disorder; Surveys and Questionnaires; Treatment Outcome

2016

Other Studies

3 other study(ies) available for ramelteon and Parkinson Disease

Article	Year
Microglial MT1 activation inhibits LPS-induced neuroinflammation via regulation of metabolic reprogramming. Aging cell, 2021, Volume: 20, Issue:6 Topics: Animals; Disease Models, Animal; Indenes; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Microglia; Neurodegenerative Diseases; Parkinson Disease; Receptor, Melatonin, MT1	2021
Ramelteon ameliorated 1-methyl-4-phenylpyridinium (MPP+)-induced neurotoxicity in neuronal cells in a mitochondrial-dependent pathway. Bioengineered, 2021, Volume: 12, Issue:1 Topics: 1-Methyl-4-phenylpyridinium; Apoptosis; Cell Line, Tumor; Humans; Indenes; Mitochondria; Neurons; Neuroprotective Agents; Oxidative Stress; Parkinson Disease	2021
Use of ramelteon for the treatment of secondary REM sleep behavior disorder. Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:18 Topics: Aged; Clonazepam; Female; Humans; Indenes; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Polysomnography; Receptors, Melatonin; REM Sleep Behavior Disorder; Sleep Apnea Syndromes	2013